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Bioethics and the Brain
Abstract
Microelectronics and medical imaging are bringing us closer to a world where mind reading is possible and
blindness banished - but we may not want to live there. New ways of imaging the human brain and new
developments in microelectronics are providing unprecedented capabilities for monitoring the brain in real
time and even for controlling brain function. The technologies are novel, but some of the questions that they
will raise are not. Electrical activity in the brain can reveal the contents of a person's memory. New imaging
techniques might allow physician to detect devastating diseases long before those diseases become clinically
apparent. And researchers may one day find brain activity that correlates with behavior patterns such as
tendencies toward alcoholism, aggression, pedophilia, or racism. But how reliable will the information be, how
should it be used, and what will it do to our notion of privacy? Meanwhile, microelectronics is making access
to the brain a two-way street. The same electrical stimulation technologies that allow some deaf people to hear
could be fashioned to control behavior as well. What are the appropriate limits to the use of this technology?
Ethicists are only now beginning to take note of these developments in neuroscience.
Comments
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The technologies are novel, but some
of the questions that they will raise are
not. Electrical activity in the brain can
reveal the contents of a person’s memory.
New imaging techniques might allow
physicians to detect devastating diseases
long before those diseases become clini-
cally apparent. And researchers may one
day find brain activity that correlates with
behavior patterns such as tendencies
toward alcoholism, aggression, pedophilia,
or racism. But how reliable will the infor-
mation be, how should it be used, and
what will it do to our notion of privacy? 
Meanwhile, microelectronics is mak-
ing access to the brain a two-way street.
The same electrical stimulation technolo-
gies that allow some deaf people to hear
could be fashioned to control behavior as
well. What are the appropriate limits to
the use of this technology? In an age of
overcrowded prisons, might society be
tempted to release criminals if behavior-
modifying brain implants could guarantee
that they would pose no further threat?
Truth and consequences
Coupled with powerful microelectronics,
science’s understanding of the brain is
opening the door to new ways of han-
dling criminal investigations and screen-
ing potential employees. Several recent
applications involve variants of the “guilty
knowledge” test, in which investigators try
to determine the presence or absence of
specific memories implying a person’s
guilt by recording electric signals from
the head.
So-called brain fingerprinting is the
most striking of these. Lawrence A. Far-
well, chairman and chief scientist of Brain
Fingerprinting Laboratories Inc. (Fairfield,
Iowa), a commercial venture, invented the
technique. Farwell claims that brain fin-
gerprinting allows investigators to “detect
information stored in the human brain”
for use in forensic examinations. He pro-
motes the method for evaluating criminal
suspects and screening for terrorists.
The system that performs brain fin-
gerprinting resembles an electroen-
cephalogram (EEG) under computer
control. In a test, the subject is seated in
front of a computer screen, wearing a
headband with EEG sensors. A series
of words, sounds, or images is pre-
sented. Some of these are called “irrel-
evants”: words or images unrelated to
the crime or to the investigation. Irrele-
vants establish a baseline of activity for
unimportant information.
Others are “target” stimuli: phrases or
images that the subject has been told to
pay particular attention to. Targets act as a
baseline for information noteworthy to
the subject. Finally, there are “probes”:
details of the crime under investigation
that an innocent would have no knowl-
edge of, such as a picture of a sofa on
which a murder victim’s body was found.34
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N
ancy, an airline pilot,
arrived promptly for a rou-
tine physical. She’d had
exams before, but this
time was different. She
was asked to lie down and place her head in
a large metallic torus, while a video screen
flashed a series of images before her eyes—
the inside of a 747 cockpit, a view of a tar-
get seen through a rifle’s scope, a chemical
formula for polyester, a photo of Bill Clin-
ton. In an adjacent room, a technician
watched as colorful images of Nancy’s
brain appeared on his computer screen,
lighting up like brushfires with different
hues in response to the pictures. As the test
ended, the technician forwarded the results
to Nancy’s employer.
Reporting for work the next day, Nancy
was confronted by her supervisor and an
official from the U.S. Federal Aviation
Administration. They informed her that
the brain images showed Nancy might
develop schizophrenia, and had a surpris-
ing familiarity with assault rifles as well.
The agency revoked her pilot’s license. The
airline promptly fired her.
This scenario is fiction. But the
basics of the technologies it alludes to
already exist. New ways of imaging the
human brain and new developments in
microelectronics are providing unprece-
dented capabilities for monitoring the
brain in real time and even for control-
ling brain function.
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In response to these cues, microvolt
electrical signals that correspond to brain
activity, known as event-related potentials
(ERPs), can be measured on the scalp at
times ranging from a few tenths of a sec-
ond to about a full second after the cue.
Distinctive ERPs occur when a subject
reacts strongly to a meaningful event. For
example, a murderer might respond to
the probe photograph of the sofa. 
Such a reaction would result in a spe-
cial ERP that includes the so-called P-
300 wave. P-300 is a well-researched
response that begins 300 ms after the
photo appears and is thought to corre-
spond to the brain’s recognizing a note-
worthy bit of information. By comparing
the ERPs from probes, targets, and irrel-
evants using a computer algorithm, Far-
well claims the system can determine
whether the probes represent informa-
tion that is known to the subject—guilty
knowledge [see traces, above].
Brain fingerprinting may seem simi-
lar to a polygraph (usually called a lie
detector), but it differs in important ways.
A polygraph measures physiologic re-
sponses such as heart rate, sweating,
breathing, and other processes that are
only indirectly related to brain function.
Brain fingerprinting’s information comes
directly from brain function. It and other
related tests do not measure truthfulness,
but seek to determine whether the subject
has a particular memory.
Already brain fingerprinting has been
used in two criminal investigations. One
was an attempt to win a new trial for Terry
Harrington, imprisoned in Iowa for 22
years for murder. Farwell claims that his
test shows that Harrington did not commit
the crime. A second case involved a man
accused of rape and murder in Missouri.
Shortly after being found guilty by brain fin-
gerprinting, the suspect (who volunteered
to take the test) confessed.
Despite having been financed in part
by the U.S. Central Intelligence Agency,
brain fingerprinting has struck out there
and with other government agencies con-
cerned with security, such as the U.S.
Federal Bureau of Investigation and the
U.S. Secret Service. Those agencies find
brain fingerprinting to be of little use in
screening for potential terrorists, spies, or
other security risks, according to a 2001
U.S. General Accounting Office study.
The reason is that the technology can’t
work without specific information
known only to the test designers and to
guilty people but not to innocents. In the
report, the agencies also express concerns
we will soon face the kind of battles that now
exist concerning the validity of genetic evi-
dence or even polygraphs.
Imaging brain function
Brain fingerprinting is not the only way to
monitor the brain to reveal when some-
one is being deceptive. Functional mag-
netic resonance imaging, or fMRI, which
tells what parts of the brain are active by
watching for changes in blood oxygen lev-
els, can do the job, too. Functional MRI is
a variant of MRI, which images the dis-
tribution in the body of protons and other
nuclei—mostly in water—by picking up
their RF signal when the nuclei are in a
strong magnetic field and perturbed by
pulses of RF energy. Through the effects
on the signal caused by hemoglobin in
NEUROTECHNOLOGY
Brain Fingerprinting
Larry Farwell [photo, opposite page]
invented a system that, he claims, detects
the presence  of specific information  in the
brain by measuring microvolt signals at the
scalp. By analyzing the differences among
signals prompted by three types of
informational cues, the system determines
whether the information is present [left] or
absent [right] in the brain.
about the reliability of the method.
Still, the technique is likely to see use in
criminal investigations by expert witness-
es testifying in court proceedings. Should
judges allow such testimony? One already
has. In March 2001, Iowa District Court
Judge Timothy O’Grady ruled that brain
fingerprinting was admissible in Harring-
ton’s quest for a new trial. But O’Grady
wasn’t swayed by brain fingerprinting evi-
dence that seemed to exonerate the defen-
dant, and the judge denied him a new trial.
O’Grady’s decision, however, was reversed
by the Iowa Supreme Court last February.
But before brain fingerprinting becomes
established as a forensic tool, its accuracy
surely needs to be assessed. Farwell claims
the system has had a perfect record in tests.
Such claims are simply premature; the
method has received very limited testing,
and much of that has been done under arti-
ficial laboratory conditions, a problem noted
by the federal report. If its validity as a foren-
sic tool is not independently established,
the blood that has lost its oxygen, fMRI
can sense blood oxygen levels.
An fMRI experiment reported in 2002
by Daniel D. Langleben, an assistant pro-
fessor of psychiatry at the University of
Pennsylvania (Philadelphia), found highly
significant correlations between lying or
truth telling and the metabolic activity in
regions of the brain important to paying
attention and monitoring and controlling
errors. Langleben’s technique has not yet
been applied to forensic examinations.
But fMRI and MRI have other useful,
though ethically complex, applications. MRI
has long acted as a diagnostic tool for finding
brain tumors, strokes, and other serious con-
ditions by observing gross damage to tissue.
Recently, physicians have begun to hope that
MRI and other imaging techniques would
prove useful in diagnosing psychiatric disor-
ders such as schizophrenia, perhaps  before
the symptoms of those disorders appear.
Those hopes are beginning to bear fruit.
MRI and positron emission tomogra-
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phy (PET), which employs radioactive trac-
ers to image brain activity, have become
sensitive enough to map the presence of
more than a dozen chemicals critical to
brain function. These include glucose, an
energy source for metabolism, and neuro-
transmitters, chemicals that relay nerve sig-
nals between brain cells. Using these new
capabilities, researchers have recently dis-
covered subtle changes in brain structure or
function that correlate to disease. The
result, as a number of investigators have
pointed out in professional journals, is a
fundamental change in how physicians
view psychiatric disorders.
For example, Gin S. Malhi and col-
leagues at the University of New South
Wales (Sydney, Australia) report that MRI
and PET studies have identified specific
changes in brain chemistry associated 
with a range of problems, including
Alzheimer’s disease, schizophrenia, alco-
holism, anxiety disorders, and post-trau-
matic stress disorder.
Similarly, the University of Toronto’s
Cheryl L. Grady and colleagues report that
MRI and PET imaging can spot regions of
the brain associated with emotion and how
we perceive the emotional responses of
others in social situations [see chart, p.
38]. Thus, for example, imaging can indi-
cate which areas of the brain mediate emo-
tional responses and our perception of
them. This implies that the technology has
the potential, so far unexplored, for prob-
ing emotional responses in people, regard-
less of how well such responses are hidden.
As this work moves from the research
lab into clinical practice, urgent questions
will arise. Who should receive pre-symp-
tomatic testing for disease—persons at
high risk of inheriting a disease; relatives
of those with a particular mental illness;
those with particular jobs like Nancy’s?
What counseling should a patient receive
when a test indicates a likelihood of devel-
oping Alzheimer’s or schizophrenia? And
what treatment, if there is any, should
such patients receive? A complicating fac-
tor is that the tests are not necessarily
definitive, but may indicate only the prob-
ability of developing the disease. And is
probability enough for making life-alter-
ing decisions for yourself, your employees,
or anyone else?
Brain-computer interfaces
Simply observing the brain is sufficient
for some applications, but others require
communicating with it. Physicians have
long measured electrical potentials from
the body and stimulated body processes
by means of implanted electrodes—
think of the pacemaker. New techniques
allow sophisticated circuits to interact
with the brain and neural tissue.
Some 30 000 people worldwide already
have their hearing enabled by cochlear
implants. Unlike a traditional hearing aid,
which simply amplifies sound that enters
the ear canal, cochlear implants transduce
sound from an external microphone and
relay the signal to electrode arrays that
directly stimulate nerve fibers in the inner
ear, bypassing much of the auditory sys- 37TH
O
M
A
S
 A
L
L
E
M
A
N
IE
E
E
S
P
E
C
T
R
U
M
•
Ju
n
e 2003
38
IE
E
E
S
P
E
C
T
R
U
M
•
Ju
n
e 
20
03
tem entirely. This device has created
unforeseen dilemmas.
Conceived by their developers as a cure
for deafness, cochlear implants were seen
in a very different light by some of their
intended recipients. Some deaf people
reject the notion that deafness is a medical
condition that needs to be treated. And so,
though the controversy has abated in the
last decade, some saw the cochlear implant
as antagonistic to the deaf community.
They were, for instance, concerned that
children fitted with the implants might not
learn sign language, setting them apart
from others with their condition.
Other devices for stimulating the brain
using implanted electrodes are not far off.
A visual prosthesis, which directly stimu-
lates the visual cortex, promises to help
people blinded by degenerative retinal dis-
ease. This approach has been pursued for
several years by groups at the University of
Utah (Salt Lake City), the nonprofit Hunt-
ington Research Institutes (Pasadena,
Calif.), and elsewhere. These investigators
hope to implant arrays of microelectrodes
into the visual cortex of the brain, at the
may improve, but implantation here, as
with artificial eyes, is a tricky business.
While few would argue against using
electrical stimulation to assist those 
with disabilities and impairments,
researchers have proven that similar
technology can be used to control behav-
ior. A sensational, and very controver-
sial, example occurred in the late 1960s,
when Spanish investigator José Delgado
implanted electrodes into the brain of a
bull and induced it to charge at him.
Just before impact, an assistant activated
the electrodes using a radio frequency
transmitter and the bull suddenly
stopped his rush.
A far more sophisticated example is
“Robo Rat,” described by Sanjiv Talwar and
co-workers at the State University of New
York’s Downstate Medical Center (Brook-
lyn) in Nature last year. The investigators
implanted electrodes in the brains of rats
that were connected to radio frequency
receivers attached to the animals’ backs. By
stimulating different parts of the brain, the
investigators could provide cues to the rats
and reward them by stimulating the pleas-
Brain Region                Autism         Schizophrenia        Depression           PTSD
Orbitofrontal 
cortex
Amygdala
Fusiform 
gyrus
Ventrolateral PFC
Subgenual 
cingulate
Rostral 
cingulate
Superior 
temporal sulcus
Dorsomedial PFC
Dorsolateral PFC
Dorsal 
cingulate
PFC = Prefrontal cortex
PTSD = Post-traumatic stress disorder
Decreased activity
Equivalent 
back of the skull, to excite neurons so as to
produce images that are taken by an exter-
nal camera. Daunting technical problems
remain, not least of which is the extensive
variation in the wiring among neurons in
different individuals, which makes it dif-
ficult to determine exactly where to place
the electrodes.
Computer-to-brain interfaces can
work in the other direction as well, using
electric signals from the brain to control
a prosthesis, software program, or robot,
for example. Such systems might assist
patients with severe motor impairments
like the late stage of amyotrophic lateral
sclerosis. But despite sometimes hyper-
bolic claims regarding such experimental
interfaces, they are far from ready to
move beyond the laboratory.
One difficulty is the low rate of data
transfer (tens of bits per minute) that
can be achieved from recordings from
the scalp. Such rates are sufficient to
allow enhanced communication with
patients but not enough to control pros-
theses. If electrodes are implanted
directly into the brain, the bandwidth
Increased activity
Revealing 
the Mark 
of Illness
Scientists have identified 10
regions of the brain [images,
right] that are important to
social cognition, that is, 
the ability to interpret and 
predict another person’s
behavior and general inter-
action in complex social 
situations. Problems 
with social cognition are
symptoms of several
psychiatric disorders. People
with diseases such as autism,
schizophrenia, depression, 
and post-traumatic stress
disorder show different levels
of brain activity in these areas,
compared with healthy people,
and medical imaging can
detect these deviations. 
Source: Dr. Cheryl Grady, Rotman Research Institute  
or
or
or or
ure center of their brains. The rats quickly
learned to respond to the investigators’
commands, transmitted from as far as 500
meters away.
Such technology has nothing to do
with the fantasies of mind control by
electromagnetic fields, long a staple of
science fiction and lately of conspiracy
theory Web sites. Nevertheless, its exis-
tence raises ethical issues. When, if
ever, is it acceptable to manipulate
someone’s brain to make him perform
actions that he would not ordinarily
take voluntarily?
Even the more obviously benevolent
brain-computer interfaces, such as
cochlear implants, are loaded with diffi-
cult decisions that may not be immedi-
ately obvious. Assuming all the technical
problems are solved and the quality of
brain-computer interfaces and implants
improves, they could be considered a
cure for deafness or blindness. And, if a
cure exists for these conditions, do peo-
ple have the right to remain deaf or blind
if they so choose? Should they be com-
pelled to use the technology, and must
society continue to accommodate them
with Braille instructions and closed-cap-
tion television if they opt to reject it?
Neuroethics: an emerging field
Ethicists are only now beginning to take
note of these developments in neuro-
science. Meetings on the subject have
been held recently on both the East
Coast (sponsored by the Center for
Bioethics at the University of Pennsyl-
vania) and West Coast (hosted jointly by
Stanford University and the University
of California at San Francisco). The
European Commission  stepped in ear-
lier, financing a research project on “Eth-
ical, Legal, and Social Aspects of Brain
Research” that began in 1997.
One central problem of neuroethics
is in establishing the appropriate limits
of human intervention in our cognitive
(knowledge processing) and affective
(emotional) functioning. Should the
contents of our minds be sacrosanct, or
should police, doctors, employers,
school administrators, or parents have
the right to probe into a person’s hon-
esty, motivations, phobias, memory, apti-
tudes, or state of health? How far should
we go in using technology to enhance
our abilities, and who should have
access to and control over the technolo-
gies we use?
Some of the prospective ethical
dilemmas raised by neuroscience are
similar to those that concern many ethi-
cists about genetics. One important
question is: how do we minimize the
harm to an individual caused by an
incorrect test result? Professionals devel-
oping the technologies described in this
article must take this issue far more seri-
ously than they have so far.
All tests will sometimes produce
incorrect results, either a false positive
(finding disease when none exists) or a
false negative (overlooking a real case of
disease). A test that indicates the pres-
ence of (or risk of developing) severe
psychiatric disorders will have obvious
effects on insurance, job opportunities,
marriage, childbearing, and other im-
portant aspects of a person’s life.
What will happen, for example, if neu-
roscience succeeds in determining that a
child is susceptible to schizophrenia or a
late-onset disease like Alzheimer’s? Is
the appropriate response prophylactic
medication, changes in lifestyle, or the
avoidance of environments that could
cause stress? The ability to diagnose early
stages of Alzheimer’s, for example, has
far outstripped the development of effec-
tive therapies for this devastating condi-
tion. Should people plan their lives
around the probabilistic potential indi-
cated by a brain scan?
The problem of probability haunts the
use of brain imaging for criminal inves-
tigation or in employment screening of
individuals, as well. A recent study by
the U.S. National Research Council—an
organization that is affiliated with the
U.S. National Academies (Washington,
D.C.)—deemed polygraphs too unreli-
able for the job of screening groups of
people for potential security risks. Brain
imaging, by providing information
directly from the brain itself, may be
more reliable than polygraphy—but just
how reliable is it? We need to know,
because if we come to rely on it, a false
positive result could destroy a career; a
false negative could leave society at risk.
The consequences of new technolo-
gies derived from neuroscience, as with
all new technologies, are hard to predict.
Cochlear implants aroused great contro-
versy in the deaf community for reasons
unforeseen by the engineers, physiolo-
gists, and physicians who developed
them. Retinal prostheses, brain-con-
trolled robots, and similar devices have
the potential to improve the lives of the
people who receive them, but these tech-
nologies will certainly bring negative con-
sequences that we cannot clearly fore-
see. Even if we can never fully anticipate
the impact of employing these technolo-
gies, it is important to try. •
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To Probe Further
Two recent reviews of uses of MRI in
psychiatry are “Magnetic Resonance
Spectroscopy and Its Applications in
Psychiatry,” by G.S. Malhi, et al., Aus-
tralian and New Zealand Journal of Psy-
chiatry, Vol. 36, 2002, pp. 31–43, and
“Studies of Altered Social Cognition in
Neuropsychiatric Disorders Using
Functional Neuroimaging,” by Cheryl
L. Grady and Michelle L. Keightley,
Canadian Journal of Psychiatry, Vol.
47, May 2002, pp. 327–36. 
Using brain wave signals to evaluate
memory is explained in “The Role of
Psychophysiology in Clinical Assess-
ment: ERPs in the Evaluation of Memo-
ry,” by J.J.B. Allen, Psychophysiology,
Vol. 39, May 2002, pp. 261–80. 
Brain Fingerprinting Laboratories’ 
Web site is located at http://www.
brainwavescience.com/. 
Connections between the brain and
computers are reviewed in  “Brain-Com-
puter Interfaces for Communication and
Control,” by J.R. Wolpaw, et al., Clinical
Neurophysiology, Vol. 113, no. 6, 2002,
pp. 767–91.
Also see “Visual Prostheses,” by E.M.
Maynard, Annual Review of Biomedical
Engineering, 2001, pp. 145–68.
For copies of the National Research
Council report on polygraphs, go to
http://www.nap.edu.
The ethical issues surrounding phar-
maceuticals for the brain are found
in  “Treatment, Enhancement, and
the Ethics of Neurotherapeutics,” by
P.R. Wolpe, Brain and Cognition, Vol.
50, 2002, pp. 387–95.
